Roch unit 8 UNIT 8 DISCUSSION Instructions: For each of the learning objectives, provide an analysis of how the course supported each

Roch unit 8

UNIT 8 DISCUSSION

Instructions:

For each of the learning objectives, provide an analysis of how the course supported each objective.

1. Discriminate among the mechanisms of action for the major classes of drugs/medications

2. Critique evidence that supports proposed pharmacotherapeutic protocols for appropriateness of application across the lifespan

3. Integrate the teaching-learning needs of clients across the lifespan when proposing pharmacotherapies

4. Propose prescriptive therapies for selected clients evaluating safety factors while utilizing knowledge of how current health status, age, gender, culture, genetic factors, ethical concerns and prescriptive authority impact decision making

Explain how the material learned in this course, based upon the objectives, will be applicable to professional application.

Provide evidence (citations and references) to support your statements and opinions.

All references and citations should in APA format.

This Unit 8 discussion post does not require any peer responses and must be submitted by Tuesday at 11:59am (noon) of week 8.

Estimated time to complete: 1 hour

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial Hospital.  One of your tasks is applying applicable laws, policies, and procedures for ROI. For each scenario, describe the decision you render.  Answer the two questions that follow.

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective? What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment